Anti-NEUFC/ CYB5D2 functional antibody

Anti-NEUFC/ CYB5D2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CYB5D2/CYB5D2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0136-Ab-1/ GM-Tg-hg-SE0136-Ab-2Anti-Human CYB5D2 monoclonal antibodyHuman
GM-Tg-rg-SE0136-Ab-1/ GM-Tg-rg-SE0136-Ab-2Anti-Rat CYB5D2 monoclonal antibodyRat
GM-Tg-mg-SE0136-Ab-1/ GM-Tg-mg-SE0136-Ab-2Anti-Mouse CYB5D2 monoclonal antibodyMouse
GM-Tg-cynog-SE0136-Ab-1/ GM-Tg-cynog-SE0136-Ab-2Anti-Cynomolgus/ Rhesus macaque CYB5D2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0136-Ab-1/ GM-Tg-felg-SE0136-Ab-2Anti-Feline CYB5D2 monoclonal antibodyFeline
GM-Tg-cang-SE0136-Ab-1/ GM-Tg-cang-SE0136-Ab-2Anti-Canine CYB5D2 monoclonal antibodyCanine
GM-Tg-bovg-SE0136-Ab-1/ GM-Tg-bovg-SE0136-Ab-2Anti-Bovine CYB5D2 monoclonal antibodyBovine
GM-Tg-equg-SE0136-Ab-1/ GM-Tg-equg-SE0136-Ab-2Anti-Equine CYB5D2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0136-Ab-1/ GM-Tg-hg-SE0136-Ab-2; GM-Tg-rg-SE0136-Ab-1/ GM-Tg-rg-SE0136-Ab-2;
GM-Tg-mg-SE0136-Ab-1/ GM-Tg-mg-SE0136-Ab-2; GM-Tg-cynog-SE0136-Ab-1/ GM-Tg-cynog-SE0136-Ab-2;
GM-Tg-felg-SE0136-Ab-1/ GM-Tg-felg-SE0136-Ab-2; GM-Tg-cang-SE0136-Ab-1/ GM-Tg-cang-SE0136-Ab-2;
GM-Tg-bovg-SE0136-Ab-1/ GM-Tg-bovg-SE0136-Ab-2; GM-Tg-equg-SE0136-Ab-1/ GM-Tg-equg-SE0136-Ab-2
Products NameAnti-CYB5D2 monoclonal antibody
Formatmab
Target NameCYB5D2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CYB5D2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0136-Ag-1Recombinant multi-species NEUFC/ CYB5D2 protein


    Target information

    Target IDGM-SE0136
    Target NameCYB5D2
    Gene ID124936,192986,303293,708196,489437,101086514,515356,100060725
    Gene Symbol and Synonyms9330151E16Rik,CYB5D2,Gm2,LOC101086514
    Uniprot AccessionQ8WUJ1,Q6AY62
    Uniprot Entry NameNEUFC_HUMAN,NEUFC_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000167740
    Target ClassificationN/A

    The target: CYB5D2, gene name: CYB5D2, also named as . Predicted to enable heme binding activity. Predicted to be involved in nervous system development. Predicted to act upstream of or within positive regulation of neuron differentiation. Predicted to be located in extracellular region. Predicted to be active in endomembrane system and membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.